Bionomics Ltd
ASX:BNO
Bionomics Ltd
ASX:BNO
Price:
0.01
AUD
Market Closed
Market Cap:
AU$13.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Bionomics Ltd
ASX:BNO
|
AU |
|
South Port New Zealand Ltd
NZX:SPN
|
NZ |
|
Bpost SA
XBRU:BPOST
|
BE |
|
Kosmos Energy Ltd
NYSE:KOS
|
US |
|
Finning International Inc
TSX:FTT
|
CA |
|
CAP XX Ltd
LSE:CPX
|
AU |
|
Ulusoy Elektrik Imalat Taahhut ve Ticaret AS
IST:ULUSE.E
|
TR |
|
PolyPid Ltd
NASDAQ:PYPD
|
IL |
|
A
|
Adgar Investments and Development Ltd
TASE:ADGR
|
IL |
|
C
|
CEMEX Holdings Philippines Inc
XPHS:CHP
|
PH |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BNO.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BNO
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
BNO Competitors Multiples
Bionomics Ltd Competitors
Bionomics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Bionomics Ltd
ASX:BNO
|
14.7m AUD | 55.7 | -0.6 | 0.6 | 0.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
